Bio-Rad Laboratories, Inc. (BIO) Free cash flow 2016–2025
Bio-Rad Laboratories, Inc. (BIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$374.6MFY2025 · since FY2016: $74.6M → $374.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $374.6M | +29.4% |
| FY2024 | $289.6M | +32.7% |
| FY2023 | $218.2M | +167.4% |
| FY2022 | $81.6M | -84.8% |
| FY2021 | $535.7M | +12.4% |
| FY2020 | $476.4M | +32.6% |
| FY2019 | $359.4M | +130.9% |
| FY2018 | $155.7M | +2263.6% |
| FY2017 | -$7.2M | -109.6% |
| FY2016 | $74.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice